JP2019147801A5 - - Google Patents

Download PDF

Info

Publication number
JP2019147801A5
JP2019147801A5 JP2019067955A JP2019067955A JP2019147801A5 JP 2019147801 A5 JP2019147801 A5 JP 2019147801A5 JP 2019067955 A JP2019067955 A JP 2019067955A JP 2019067955 A JP2019067955 A JP 2019067955A JP 2019147801 A5 JP2019147801 A5 JP 2019147801A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
sequence
acid sequence
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019067955A
Other languages
English (en)
Japanese (ja)
Other versions
JP6732990B2 (ja
JP2019147801A (ja
Filing date
Publication date
Priority claimed from GBGB1114858.2A external-priority patent/GB201114858D0/en
Application filed filed Critical
Publication of JP2019147801A publication Critical patent/JP2019147801A/ja
Publication of JP2019147801A5 publication Critical patent/JP2019147801A5/ja
Application granted granted Critical
Publication of JP6732990B2 publication Critical patent/JP6732990B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019067955A 2011-05-06 2019-03-29 抗神経成長因子抗体並びに前記抗体の製造及び使用方法 Active JP6732990B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161483481P 2011-05-06 2011-05-06
US61/483,481 2011-05-06
GB1114858.2 2011-08-29
GBGB1114858.2A GB201114858D0 (en) 2011-08-29 2011-08-29 Anti-nerve growth factor antibodies and methods of using the same
US201161531439P 2011-09-06 2011-09-06
US61/531,439 2011-09-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017031939A Division JP2017101064A (ja) 2011-05-06 2017-02-23 抗神経成長因子抗体並びに前記抗体の製造及び使用方法

Publications (3)

Publication Number Publication Date
JP2019147801A JP2019147801A (ja) 2019-09-05
JP2019147801A5 true JP2019147801A5 (enExample) 2019-10-24
JP6732990B2 JP6732990B2 (ja) 2020-07-29

Family

ID=50931152

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015239920A Active JP5969102B2 (ja) 2011-05-06 2015-12-09 治療用イヌ免疫グロブリンおよびそれを用いる方法
JP2017031939A Pending JP2017101064A (ja) 2011-05-06 2017-02-23 抗神経成長因子抗体並びに前記抗体の製造及び使用方法
JP2019067955A Active JP6732990B2 (ja) 2011-05-06 2019-03-29 抗神経成長因子抗体並びに前記抗体の製造及び使用方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015239920A Active JP5969102B2 (ja) 2011-05-06 2015-12-09 治療用イヌ免疫グロブリンおよびそれを用いる方法
JP2017031939A Pending JP2017101064A (ja) 2011-05-06 2017-02-23 抗神経成長因子抗体並びに前記抗体の製造及び使用方法

Country Status (3)

Country Link
US (3) US9580496B2 (enExample)
JP (3) JP5969102B2 (enExample)
GB (1) GB2528401A (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8587771B2 (en) * 2010-07-16 2013-11-19 Microsoft Corporation Method and system for multi-phase dynamic calibration of three-dimensional (3D) sensors in a time-of-flight system
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
HUE046249T2 (hu) * 2013-12-12 2020-02-28 Shanghai hengrui pharmaceutical co ltd PD-1 antitest, antigén-kötõ fragmense, és gyógyászati alkalmazása
EP4124624A3 (en) 2013-12-20 2023-05-03 Intervet International B.V. Antibodies against canine pd-1
CA2935960C (en) 2014-01-08 2023-01-10 Bart Lipkens Acoustophoresis device with dual acoustophoretic chamber
CA2961987A1 (en) 2014-09-30 2016-04-07 Intervet International B.V. Pd-l1 antibodies binding canine pd-l1
US9758575B2 (en) * 2015-04-06 2017-09-12 Yung Shin Pharmaceutical Industrial Co. Ltd. Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
JP2018526003A (ja) * 2015-08-31 2018-09-13 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア イヌの癌を治療するためのキメラaav−抗vegf
US11091556B2 (en) 2015-12-18 2021-08-17 Intervet Inc. Caninized human antibodies to human IL-4R alpha
CA3005696A1 (en) 2015-12-18 2017-06-22 Intervet International B.V. Caninized human antibodies to human and canine il-4r alpha
JP6910963B2 (ja) 2016-01-06 2021-07-28 株式会社オーダーメードメディカルリサーチ 高親和性抗vegf抗体
JP6925981B2 (ja) 2016-01-06 2021-08-25 株式会社オーダーメードメディカルリサーチ Vegfとnrp1との結合を阻害する抗体
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US10928489B2 (en) * 2017-04-06 2021-02-23 Microsoft Technology Licensing, Llc Time of flight camera
US10215856B1 (en) 2017-11-27 2019-02-26 Microsoft Technology Licensing, Llc Time of flight camera
US10901087B2 (en) 2018-01-15 2021-01-26 Microsoft Technology Licensing, Llc Time of flight camera
US10942274B2 (en) 2018-04-11 2021-03-09 Microsoft Technology Licensing, Llc Time of flight and picture camera
US10895925B2 (en) 2018-10-03 2021-01-19 Microsoft Technology Licensing, Llc Touch display alignment
US11435476B2 (en) 2018-10-12 2022-09-06 Microsoft Technology Licensing, Llc Time-of-flight RGB-IR image sensor
JP2021059499A (ja) 2019-10-03 2021-04-15 日本全薬工業株式会社 イヌcd20に対するモノクローナル抗体又は抗体フラグメント
US11079515B2 (en) 2019-12-18 2021-08-03 Microsoft Technology Licensing, Llc Micro lens time-of-flight sensor having micro lens heights that vary based on image height
EP4230732B1 (en) 2021-07-30 2025-01-22 Chengdu Unovel Biopharma Co., Ltd. Recombinant cho cell, construction method therefor, and detection system and method using same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2837240B2 (ja) * 1990-06-07 1998-12-14 財団法人化学及血清療法研究所 イヌ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×イヌキメラ抗体
GB9202796D0 (en) 1992-02-11 1992-03-25 Wellcome Found Antiviral antibody
WO2001077332A2 (en) 2000-04-07 2001-10-18 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
US20030190705A1 (en) 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
AU2002359851A1 (en) * 2001-12-21 2003-07-30 Idexx Laboratories, Inc. Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
KR20050111598A (ko) * 2003-02-19 2005-11-25 리나트 뉴로사이언스 코퍼레이션 신경 성장 인자 길항제 및 nsaid를 투여함으로써통증을 치료하는 방법 및 그것을 함유하는 조성물
JP2005104936A (ja) * 2003-10-01 2005-04-21 Nippon Zenyaku Kogyo Kk イヌtarc抗体
JP2005143436A (ja) * 2003-11-18 2005-06-09 Nippon Zenyaku Kogyo Kk イヌmdc
ITRM20030601A1 (it) 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
US7462697B2 (en) * 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
ITRM20050290A1 (it) * 2005-06-07 2006-12-08 Lay Line Genomics Spa Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
CN103897063B (zh) * 2007-06-01 2017-04-12 马里兰大学巴尔的摩分校 免疫球蛋白恒定区Fc受体结合剂
WO2010027488A2 (en) 2008-09-04 2010-03-11 Vet Therapeutics, Inc. Monoclonal antibodies
US8569460B2 (en) 2009-03-25 2013-10-29 Vet Therapeutics, Inc. Antibody constant domain regions and uses thereof
WO2010117448A2 (en) 2009-04-05 2010-10-14 Provenance Biopharmaceuticals Corp. Chimeric immunocytokines and methods of use thereof
WO2012024650A2 (en) 2010-08-19 2012-02-23 Abbott Laboratories Anti-ngf antibodies and their use
AU2012252152B2 (en) 2011-05-06 2016-07-07 Zoetis Services Llc Anti-nerve growth factor antibodies and methods of preparing and using the same

Similar Documents

Publication Publication Date Title
JP2014522236A5 (enExample)
JP7041516B2 (ja) 共通軽鎖を有する二重特異性抗体又は抗体混合物
JP2014519317A5 (enExample)
JP2020514277A5 (enExample)
RU2016129113A (ru) Антитела к pd-1 собак
JP2020536532A5 (enExample)
JP2021514973A5 (enExample)
JP2019536806A5 (enExample)
JP2021531254A5 (enExample)
JP2017113028A5 (enExample)
RU2019121086A (ru) Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1)
JP2022513420A5 (enExample)
JP2016536322A5 (enExample)
WO2016207304A8 (en) Monoclonal anti-il-1racp antibodies
JP2022513043A5 (enExample)
JP2016020389A5 (enExample)
FI3484915T3 (fi) Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä
JP2014511179A5 (enExample)
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
CN102702358A (zh) 针对csf-1r的抗体
JP2016507470A5 (enExample)
JP2010526028A5 (enExample)
JP2022533538A5 (enExample)
JP2012526542A5 (enExample)
RU2010119450A (ru) Антитело против bst2